norm: elite pharmaceuticalsUSno LEI · no CIKMax severity: Low

Canonical registry

Elite Pharmaceuticals

ent_b015f3ac13268447f394298d

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: Elite Pharmaceuticals
Normalized: elite pharmaceuticals— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: No match
SEC EDGAR CIK: None — not an SEC registrant
Domain: None on record

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2024-07-01
Elite Pharmaceuticals' Form 10-K Item 1C cybersecurity disclosure describes the company's cyber risk management program aligned to the NIST Cybersecurity Framework, including annual third-party risk assessments, IPS/IDS controls, identity access management, data backups, and Audit Committee oversight. The Company states it is not aware of any cybersecurity risks that have materially affected or are reasonably likely to materially affect its business. No specific incident is disclosed.